A retrospective study of Pomalidomide, Cyclophosphamide and Dexamethasone in patients with relapsed and refractory multiple myeloma.
Latest Information Update: 21 Jan 2016
At a glance
- Drugs Pomalidomide (Primary) ; Cyclophosphamide; Dexamethasone
- Indications Multiple myeloma
- Focus Adverse reactions; Therapeutic Use
- 21 Jan 2016 New trial record
- 08 Dec 2015 Results presented at the 57th Annual Meeting and Exposition of the American Society of Hematology